These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37969014)

  • 1. HIV Prevention Among Men Who Have Sex With Men: Tenofovir Alafenamide Combination Preexposure Prophylaxis Versus Placebo.
    Zivich PN; Cole SR; Edwards JK; Glidden DV; Das M; Shook-Sa BE; Shao Y; Mehrotra ML; Adimora AA; Eron JJ
    J Infect Dis; 2024 Apr; 229(4):1123-1130. PubMed ID: 37969014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis.
    Jamieson L; Johnson LF; Nichols BE; Delany-Moretlwe S; Hosseinipour MC; Russell C; Meyer-Rath G
    Lancet HIV; 2022 Dec; 9(12):e857-e867. PubMed ID: 36356603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.
    Bekker LG; Das M; Abdool Karim Q; Ahmed K; Batting J; Brumskine W; Gill K; Harkoo I; Jaggernath M; Kigozi G; Kiwanuka N; Kotze P; Lebina L; Louw CE; Malahleha M; Manentsa M; Mansoor LE; Moodley D; Naicker V; Naidoo L; Naidoo M; Nair G; Ndlovu N; Palanee-Phillips T; Panchia R; Pillay S; Potloane D; Selepe P; Singh N; Singh Y; Spooner E; Ward AM; Zwane Z; Ebrahimi R; Zhao Y; Kintu A; Deaton C; Carter CC; Baeten JM; Matovu Kiweewa F;
    N Engl J Med; 2024 Oct; 391(13):1179-1192. PubMed ID: 39046157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Initiation of Antiretroviral Therapy With Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Versus Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate in HIV-Positive Men Who Have Sex With Men in China: Week 48 Results of the Multicenter, Randomized Clinical Trial.
    Wang R; Sun L; Wang X; Zhai Y; Wang L; Ma P; Wu C; Zhou Y; Chen R; Wang R; Zhang F; Hua W; Li A; Xia W; Gao Y; Li R; Lv S; Shao Y; Cao Y; Zhang T; Wu H; Cai C; Dai L
    Clin Infect Dis; 2024 Jul; 79(1):169-176. PubMed ID: 38236137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of combination prevention strategies on HIV incidence among gay and bisexual men who have sex with men in the UK: a model-based analysis.
    Cambiano V; Miners A; Lampe FC; McCormack S; Gill ON; Hart G; Fenton KA; Cairns G; Thompson M; Delpech V; Rodger AJ; Phillips AN
    Lancet HIV; 2023 Nov; 10(11):e713-e722. PubMed ID: 37923485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial.
    Nair G; Celum C; Szydlo D; Brown ER; Akello CA; Nakalega R; Macdonald P; Milan G; Palanee-Phillips T; Reddy K; Tahuringana E; Muhlanga F; Nakabiito C; Bekker LG; Siziba B; Hillier SL; Baeten JM; Garcia M; Johnson S; McClure T; Levy L; Livant E; Jacobson C; Soto-Torres L; van der Straten A; Hosek S; Rooney JF; Steytler J; Bunge K; Parikh U; Hendrix C; Anderson P; Ngure K;
    Lancet HIV; 2023 Dec; 10(12):e779-e789. PubMed ID: 37898146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxis.
    Webb EL; Petkov S; Yun H; Else L; Lebina L; Serwanga J; Pillay AAP; Seiphetlo TB; Mugaba S; Namubiru P; Odoch G; Opoka D; Ssemata AS; Kaleebu P; Khoo S; Martinson N; Fox J; Gray CM; Herrera C; Chiodi F
    Front Immunol; 2024; 15():1415475. PubMed ID: 39569196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Preexposure Prophylaxis Practice among Urban Female Sex Workers in Northwest Ethiopia: Using Generalized Structural Equation Modeling.
    Asmare L; Goshu A; Alemu T; Gebeye E
    J Int Assoc Provid AIDS Care; 2024; 23():23259582241302900. PubMed ID: 39632570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessment.
    Sullivan AK; Saunders J; Desai M; Cartier A; Mitchell HD; Jaffer S; Ogaz D; Chiavenna C; Charlett A; Diamente V; Golombek R; Manavi K; Priestley C; Waters LJ; Milinkovic A; McOwan A; Estcourt C; Sabin CA; Rodger A; Gold D; Gazzard BG; McCormack S; Gill ON;
    Lancet HIV; 2023 Dec; 10(12):e790-e806. PubMed ID: 38040478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-utero exposure to tenofovir-containing pre-exposure prophylaxis and bone mineral content in HIV-unexposed infants in South Africa.
    Reddy K; Naidoo KL; Lombard C; Godlwana Z; Desmond AC; Clark R; Rooney JF; Gray G; Moodley D
    J Int AIDS Soc; 2024 Nov; 27(11):e26379. PubMed ID: 39528419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 28-Day Toxicity Study of Tenofovir Alafenamide Hemifumarate by Subcutaneous Infusion in Rats and Dogs.
    Zane D; Roller S; Shelton J; Singh R; Jain R; Wang Y; Yang B; Felx M; Alessi T; Feldman PL
    Microbiol Spectr; 2021 Sep; 9(1):e0033921. PubMed ID: 34190595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care providers' decision-making and early adoption of tenofovir alafenamide for HIV preexposure prophylaxis: An inductive qualitative study.
    Merchant E; Solleveld P; Gibas K; Krakower D
    PLoS One; 2024; 19(12):e0311591. PubMed ID: 39636888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric adverse events in tenofovir disoproxil fumarate- and tenofovir alafenamide-based HIV therapy and prophylaxis: a systematic review and meta‑analysis.
    Gräfe M; Schäfer MS; Leithner C; Allers K; Schneider T; Algharably EEA; Kreutz R; Riemer TG
    Pol Arch Intern Med; 2024 Nov; 134(11):. PubMed ID: 39387623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferences for Starting Daily, On-Demand, and Long-Acting Injectable HIV Preexposure Prophylaxis Among Men Who Have Sex With Men in the United States (2021-2022): Nationwide Online Cross-Sectional Study.
    Islek D; Sanchez T; Glick JL; Jones J; Rawlings K; Sarkar S; Sullivan PS; Vannappagari V
    JMIR Public Health Surveill; 2024 Nov; 10():e62801. PubMed ID: 39536313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083.
    Mitchell KM; Boily MC; Hanscom B; Moore M; Todd J; Paz-Bailey G; Wejnert C; Liu A; Donnell DJ; Grinsztejn B; Landovitz RJ; Dimitrov DT
    Lancet Reg Health Am; 2023 Feb; 18():100416. PubMed ID: 36844011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study.
    Phillips AN; Bershteyn A; Revill P; Bansi-Matharu L; Kripke K; Boily MC; Martin-Hughes R; Johnson LF; Mukandavire Z; Jamieson L; Meyer-Rath G; Hallett TB; Ten Brink D; Kelly SL; Nichols BE; Bendavid E; Mudimu E; Taramusi I; Smith J; Dalal S; Baggaley R; Crowley S; Terris-Prestholt F; Godfrey-Faussett P; Mukui I; Jahn A; Case KK; Havlir D; Petersen M; Kamya M; Koss CA; Balzer LB; Apollo T; Chidarikire T; Mellors JW; Parikh UM; Godfrey C; Cambiano V;
    Lancet HIV; 2022 May; 9(5):e353-e362. PubMed ID: 35489378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing event-driven HIV pre-exposure prophylaxis use among gay, bisexual and other men who have sex with men in Australia: results from behavioural surveillance 2019-2023.
    Chan C; Holt M; Smith AKJ; Broady TR; MacGibbon J; Mao L; Wilcock B; Rule J; Bavinton BR
    J Int AIDS Soc; 2024 Nov; 27(11):e26398. PubMed ID: 39581846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen for adults with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.